NasdaqGM:XNCRBiotechs
Xencor (XNCR) Could Be 29% Undervalued Following Its Sharp Single Day Move
Xencor (XNCR) has drawn investor attention after a sharp single day move, with the stock closing at US$20.21. Recent trading comes against a backdrop of mixed long term returns and ongoing clinical-stage development.
See our latest analysis for Xencor.
The latest drop comes after a strong run, with Xencor posting a 34.7% 1 month share price return and a 57.3% 3 month share price return. The 1 year total shareholder return sits at 154.2% despite weaker 3 and 5 year total shareholder...